Results 131 to 140 of about 420,257 (333)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema

open access: yesBMC Ophthalmology, 2019
BackgroundDiabetic macular edema (DME) can be treated with different alternatives, among them Dexamethasone intravitreal implant 0.7 mg (DEX 0.7) has demonstrated that may improve both central macular thickness (CMT) and best corrected visual acuity ...
V. Castro-Navarro   +5 more
semanticscholar   +1 more source

Central Macular Thickness in Diabetic Macular Edema

open access: yesActa Endocrinologica (Bucharest), 2020
Retinal microvascular dysfunction differs in macular edema lesions in the two eyes of the same patient with diabetic retinopathy.To evaluate the relationship between central macular thickness (CMT) and metabolic/systemic factors including anthropometric and laboratory findings, in patients with regressed diabetic retinopathy and a history of pars plana
Güngel, H.   +4 more
openaire   +3 more sources

Sophisticated Ensemble Deep Learning Approaches for Multilabel Retinal Disease Classification in Medical Imaging

open access: yesCAAI Transactions on Intelligence Technology, EarlyView.
ABSTRACT This paper introduces a novel ensemble Deep learning (DL)‐based Multi‐Label Retinal Disease Classification (MLRDC) system, known for its high accuracy and efficiency. Utilising a stacking ensemble approach, and integrating DenseNet201, EfficientNetB4, EfficientNetB3 and EfficientNetV2S models, exceptional performance in retinal disease ...
Asghar Amir   +3 more
wiley   +1 more source

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA

open access: yesActa Biomedica Scientifica, 2016
Objective: to analyze the structural state of the central area of the retina in diabetic macular edema in the background anti-VEGF therapy. Methods. The study included 38 patients (40 eyes) with diabetic macular edema.
M. M. Bikbov   +2 more
doaj   +1 more source

Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges

open access: yesClinical Ophthalmology, 2019
Macular edema (ME) is the most common sight-threatening complication in uveitis. The diagnostic and therapeutic management of the uveitic macular edema (UME) might be challenging due to the complex diagnostic workup and the difficulties physicians face ...
H. Massa   +5 more
semanticscholar   +1 more source

Comparison of 5-year progression of retinitis pigmentosa involving the posterior pole among siblings by means of SD-OCT: a retrospective study [PDF]

open access: yes, 2018
The blockchain technology promises to transform finance, money and evengovernments. However, analyses of blockchain applicability and robustness typicallyfocus on isolated systems whose actors contribute mainly by running the consensusalgorithm. Here, we
A Hagiwara   +52 more
core   +1 more source

Juvenile idiopathic arthritis during 20 years in Sweden: Characteristics of children, therapy interventions, occurrence of uveitis and ocular complications

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To assess and compare the characteristics, therapy interventions, occurrence of uveitis and ocular complications in children with juvenile idiopathic arthritis (JIA) screened and examined for uveitis in Gothenburg, Sweden, over 20 years.
Pia Lundgren   +7 more
wiley   +1 more source

Semaglutide and non‐arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association

open access: yesActa Ophthalmologica, EarlyView.
Abstract This review covers a seminal study of the relation between exposure to the glucagon‐like peptide 1 (GLP‐1) agonist semaglutide and incident non‐arteritic anterior ischaemic optic neuropathy (NAION) in a neuro‐ophthalmology clinic setting, subsequent studies in unselected populations, a meta‐analysis of clinical trials and pathophysiology ...
Abdullah Amini   +2 more
wiley   +1 more source

Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment : evidence from the RESTORE trial [PDF]

open access: yes, 2012
Background/aims To evaluate the cost-effectiveness of ranibizumab as either monotherapy or combined with laser therapy, compared with laser monotherapy, in the treatment of diabetic macular oedema (DME) causing visual impairment from a UK healthcare ...
Annemans, Lieven   +7 more
core   +3 more sources

Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the incidence and risk factors for secondary ocular hypertension (SOHT) following intravitreal dexamethasone implants (Ozurdex®) in patients with diabetic macular oedema (DME) and macular oedema secondary to retinal vein occlusion (RVO) in a Swedish cohort.
Imadeddin Abu Ishkheidem   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy